Back to overview
Hospidex-Innomediq acquires distribution of Mindray infusion pumps in the Netherlands from QRSNews
Kimberlie Hanna
Heist-op-den-Berg – Bleiswijk Aug. 29, 2025
As of September 1, 2025, QRS will transfer the activities surrounding the distribution and support of Mindray infusion pumps in the Netherlands to Hospidex-Innomediq. For healthcare facilities and professionals, this means a seamless transition, while maintaining the familiar quality and service.
In recent years, QRS has successfully introduced and supported Mindray infusion pumps in the Dutch market. Hospidex-Innomediq, which has over sixteen years of experience in medical technology and a strong focus on innovation and customer-oriented service, is enthusiastically taking over this role.
“We are proud of what we have built with Mindray infusion pumps in the Netherlands. It is reassuring to know that Hospidex-Innomediq will continue to build on this foundation and keep customers in good hands,“ says Alex van der Putten, Managing Director QRS Group.
“With the transfer of Mindray infusion pumps, we strengthen our position in the Netherlands. Customers can count on continuity, smooth service and further support in their daily practice,“ said Yves Pauwels, Managing Director Strategic Partnerships Hospidex-Innomediq.
Nothing changes for customers: service contracts, support and product availability remain guaranteed. The combination of the base built up by QRS and the expertise of Hospidex-Innomediq forms a solid foundation for the further growth of Mindray infusion technology in the Netherlands.
Have a question about this article? Contact.

Kimberlie Hanna
MARKETING MANAGER
Please fill out the form to the right if you have questions about any of our news items. You can also ask questions about our participation in certain fairs or conferences here.

